|
Volumn 55, Issue 9-10, 2001, Pages 565-571
|
Translational research - Traffic on the bridge
a a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CANCER ANTIBODY;
CANCER VACCINE;
CELECOXIB;
DOXORUBICIN;
GLEVAC;
IMATINIB;
PACLITAXEL;
TAMOXIFEN;
ARTICLE;
AUTOMATION;
CANCER CENTER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER CONTROL;
CANCER GENETICS;
CANCER PREVENTION;
CANCER RESEARCH;
CARCINOMA;
CLINICAL PRACTICE;
CLINICAL TRIAL;
FINANCIAL MANAGEMENT;
HUMAN;
INFORMATION SCIENCE;
PATIENT;
PREVALENCE;
PRIORITY JOURNAL;
TIME;
TRAINING;
ANTINEOPLASTIC AGENTS;
HUMANS;
MEDICAL INFORMATICS COMPUTING;
MEDICAL ONCOLOGY;
NATIONAL INSTITUTES OF HEALTH (U.S.);
NEOPLASMS;
RESEARCH;
UNITED STATES;
|
EID: 0035651787
PISSN: 07533322
EISSN: None
Source Type: Journal
DOI: 10.1016/S0753-3322(01)00144-5 Document Type: Article |
Times cited : (12)
|
References (11)
|